Image may be NSFW.
Clik here to view.
Shares in Innoviva (NSDQ:INVA) rose today after the company topped expectations on Wall Street with its fourth quarter and full-year financial results.
The Brisbane, Calif.-based company posted profits of $58.4 million, or 55¢ per share, on sales of $69.5 million for the 3 months ended Dec. 31, for bottom-line growth of 129% on sales growth of 59% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Innoviva posts Street-beating Q4, FY17 earnings appeared first on MassDevice.
